Additionally, several recent studies suggested that tumor-killing T cell and anti-PD-L1 antibodies can induce ferroptosis in tumor cells, while liproxstatin-1 (ferroptosis depressor) can reduce the anticancer efficacy of these agents (Lang et al., 2019; Wang et al., 2019). The gene discussed is CD274; the disease is neoplasm.